| Literature DB >> 27838026 |
Charles P Gerba1, Walter Q Betancourt2, Masaaki Kitajima3.
Abstract
To ensure the safety of wastewater reuse for irrigation of food crops and drinking water pathogenic viruses must be reduced to levels that pose no significant risk. To achieve this goal minimum reduction of viruses by treatment trains have been suggested. For use of edible crops a 6-log reduction and for production of potable drinking water a 12-log reduction has been suggested. These reductions were based on assuming infective virus concentrations of 105 to 106 per liter. Recent application of molecular methods suggests that some pathogenic viruses may be occurring in concentrations of 107 to 109 per liter. Factors influencing these levels include the development of molecular methods for virus detection, emergence of newly recognized viruses, decrease in per capita water use due to conservation measures, and outbreaks. Since neither cell culture nor molecular methods can assess all the potentially infectious virus in wastewater conservative estimates should be used to assess the virus load in untreated wastewater. This review indicates that an additional 2- to 3-log reduction of viruses above current recommendations may be needed to ensure the safety of recycled water. Information is needed on peak loading of viruses. In addition, more virus groups need to be quantified using better methods of virus quantification, including more accurate methods for measuring viral infectivity in order to better quantify risks from viruses in recycled water. Copyright ÂEntities:
Keywords: Recycle; Reduction; Reuse; Viruses; Wastewater
Mesh:
Substances:
Year: 2016 PMID: 27838026 PMCID: PMC7112101 DOI: 10.1016/j.watres.2016.11.020
Source DB: PubMed Journal: Water Res ISSN: 0043-1354 Impact factor: 11.236
Factors which influence the concentration of viruses in wastewater.
| Incidence of infection within a community |
| Social economic status of the community |
| Season |
| Per capita water use |
| Time of day |
| Age distribution within the community |
| Chronic infections |
Concentration of enteric viruses in feces.
| Enteric viruses | Per gram of feces |
|---|---|
| Enteroviruses | 103–107 |
| Rotavirus | 1010 |
| Adenovirus | 1011 |
| Norovirus | 1011 |
Enteroviruses are based on infectivity assay in cell culture and data for the other viruses are from electron micrographs.
Fig. 1Methods of virus quantification and detection in wastewater.
Factors influencing infectivity assays for viruses.
| Primary vs. continuous cell lines | Generally primary cell lines are more sensitive |
|---|---|
| Specific cell line | Numbers of viruses detected and types of viruses are dependent on the specific cell line; how many passages of the cell line have been performed |
| Assay conditions | Rocking cells, addition of certain enzymes and polyelectrolytes (e.g., trypsin), PFU vs TCID50; monolayer vs. suspended cells. |
| Ratio of viral particles to infectivity | Much lower for viruses directly isolated from human feces vs. laboratory grown viruses |
| Number of passages of the sample in cell culture | Passage of negative samples on first passage onto a second passage results in greater numbers of virus detected in a sample |
PFU = plaque forming units; TCID50 = Tissue culture infectious dose.
Concentrations of viruses in untreated wastewater as determined by cell culture assay (greatest values known).
| Maximum Concentration of virus per liter | Method of assay | Cell line | Location | Reference |
|---|---|---|---|---|
| 276,000 | PFU; 80–100% efficiency | PMK; human amnion | San Diego, California, United States of America | |
| 210,000 | TCID50 | PMK | Johannesburg, South Africa | |
| 1,106,000 | PFU; direct inoculation | BGM | Haifa, Israel | |
| 95,000 | TCID50 | PMK | Worcester and Pietermaritzburg, South Africa | |
| 210,000 | IF; reovirus only | Mouse L929 | Dugway, UT, United States of America | |
| 463,500 | TCID50 | PMK | Windhoek, Namibia |
IF = infectious foci; PMK = primary monkey kidney; BGM = Buffalo green monkey.
Concentration of viruses detected in untreated wastewater by qPCR.
| Genome copies per liter | Virus | Location | Remarks | Reference |
|---|---|---|---|---|
| 51,000,000 | Norovirus GI, GII | Tucson, Arizona, United States of America | Sample collected the same day; composite sample; 24% efficiency | |
| 15,500,000 | Adenovirus | |||
| 1,100,800 | Norovirus GI, GII | Tucson, AZ, USA | 105.3% efficiency | |
| 5,191,200 | Adenovirus | 73.8% efficiency | ||
| 31,000,000 | Rotavirus | Yungas region, Bolivia | >10% efficiency | |
| 158,000 | Norovirus GI | Kyoto, Shiga, Saitama, Osaka, Tokyo, Ibaraki, Japan | 19% efficiency | |
| 316,227 | Adenovirus | |||
| 5,700,000,000 | Norovirus GII | Central Italy | 35% efficiency | |
| 1,600,000,000 | Norovirus GI | |||
| 9,800,000,000 | Adenovirus | |||
| 1,258,925,412 | Adenovirus | Traverse City, Michigan, USA | 1 MDS method for conc. 30–50% efficiency | |
| 398,107,170 | Norovirus GII | |||
| 1,000,000,000 | Norovirus GI | Northwestern France | Composite; efficiency >10% | |
| 60,000,000 | Norovirus GII | |||
| 1,000,000,000 | Norovirus GI | Northwest France | Grab; >10% efficiency | |
| 39,810,717 | Norovirus GII | |||
| 2,200,000 | Adenovirus | Japan | Not given | |
| 510,000 | Sapovirus | |||
| 416,686,938 | Adenovirus | Several treatment plants across New Zealand | Beef extract flocculation –eff. Not given | |
| 4,677,351 | Enterovirus | |||
| 63,095,734 | Adenovirus | Edmonton, Canada | 30 to 50% efficiency | |
| 19,952,623 | Reovirus | |||
| 10,000,000 | Norovirus | |||
| 10,000,000 | Sapovirus | |||
| 12,589,254 | Norovirus GII | New Orleans, Louisiana, USA | Composite; eff. Not provided; ultracentrifugation | |
| 12,589,254 | Norovirus GI |
New viruses and new virus types excreted in feces or urine identified since 1996.
| Virus | Reference |
|---|---|
| EV73 | |
| EV 76, 89, 90, 91 | |
| EV 74-75 | |
| EV 77-78 | |
| EV 79–88, 97, and 100-101 | |
| EV 105 and EV 116 | |
| HAdV-G52 | |
| HAdV-D53 | |
| HAdV-D54 | |
| Human Astrovirus AstV-MLB1 | |
| Human Polyomavirus-9 (HPyV9) | |
| MW Polyomavirus (MWPyV) HPyV10 | |
| Merkel cell polyomavirus (MCPyV) | |
| Small circular, Rep-encoding, ssDNA (CRESS-DNA) genomes (CRESS-DNA viruses) characterized in fecal or environmental samples | |
| Human cyclovirus 1, 2 and 3 | |
| Human Bocavirus (HBoV) [HBoV-1, HBoV-2, HBoV-3, HBoV-4] | |
| Human | |
| Human | |
| Human | |
| Human picobirnavirus D strain CDC23 (HuPBV-D-CDC23) and Human picobirnavirus E strain CDC16 (HuPBV-E-CDC16) | |